Review:
Surrogate Endpoints
overall review score: 3.5
⭐⭐⭐⭐
score is between 0 and 5
Surrogate endpoints are substitute measures used in clinical research and trials to predict the actual clinical outcomes of interest, such as overall survival or disease remission. They serve as indirect markers that can provide quicker or more feasible assessments of an intervention's efficacy, especially when measuring the true endpoint directly is challenging, costly, or time-consuming.
Key Features
- Serve as proxies for true clinical outcomes
- Allow for earlier assessment of treatment effects
- Commonly used in clinical trials to expedite drug approval processes
- Require validation to ensure they accurately predict real-world benefits
- Can include biomarkers, lab measurements, or physiological indicators
Pros
- Enable faster evaluation of new therapies
- Reduce costs and duration of clinical trials
- Facilitate regulatory approval for promising treatments
- Allow earlier decision-making in clinical research
Cons
- May not always reliably predict actual clinical benefits
- Risk of overestimating a treatment's effectiveness based on surrogate data
- Validation processes can be complex and incomplete
- Potential for misleading outcomes if surrogate endpoints are poorly chosen